Systemic lupus erythematosus (SLE) is considered to be the quintessential autoimmune disease. It has not been possible to induce SLE in animal models by DNA immunization or by challenge with anti-DNA antibodies. We herewith report a murine model of SLE-like disease induced by immunization of C3H.SW female mice with a common human monoclonal anti-DNA idiotype (16/6 idiotype). Following a booster injection with the 16/6 idiotype, high levels of murine anti-16/6 and anti-anti-16/6 antibodies (associated with anti-
poly(dT), ribonucleoprotein, autoantigens [Sm, SS-A (Ro), and SS-B (La)], and cardiolipin were noted. The serological findings were associated with increased erythrocyte sedimentation rate, leukopenia, proteinuria, immune complex deposition in the glomerular mesangium, and sclerosis of the glomeruli. The immune complexes in the kidneys were shown to contain the 16/6 idiotype. This experimental SLE-like model may be used to elucidate the mechanisms underlying SLE.
Among the criteria defining antibody-mediated autoimmune disease one must precisely characterize the autoantigen, the autoantibody, and the induction of a similar condition following immunization with the autoantigen or after the passive transfer of the autoantibody. Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of multiple autoantibodies that are directed against various nuclear antigens (1) . Despite the existence of several spontaneous murine models for SLE (2) , this classical autoimmune disease could not thus far be experimentally induced. DNA, to which most of the autoantibodies are directed in SLE, is no longer regarded as the antigen initiating the disease (3) , mainly because immunization of mice with DNA could not induce SLE (4) . Furthermore, transfer of anti-DNA antibodies into mice did not result in the successful induction of SLE (5, 6) . Thus the availability of such a model may shed light on the pathogenesis of SLE.
The human monoclonal IgM antibody termed 16/6 bears a common idiotype (idiotype 16/6), defined by a specific rabbit anti-idiotypic serum (7) . The idiotype was found to have clinical relevance in SLE patients (8) . Its levels parallel the titer of anti-double-stranded DNA (dsDNA) antibody and inversely correlate with complement component concentrations in patients with SLE (8) . The presence of this idiotype was clearly demonstrated in the glomeruli and epidermal-dermal junction of patients with SLE (9, 10) .
In the present study we utilized the idiotype 16/6 to induce a SLE-like disease in a murine strain that does not develop any spontaneous immune disorder. We report here that following immunization of C3H.SW mice with the human anti-DNA monoclonal antibody 16/6, they develop a SLElike disease characterized by the major hallmarks of SLE.
MATERIALS AND METHODS
Mice. C3H.SW female mice were obtained from The Jackson Laboratory and were used at the age of 2-3 months of age.
Antibodies with the 16/6 Idiotype. The hybridoma secreting antibodies with the idiotype 16/6 was grown in culture. The antibodies with the idiotype 16/6 were precipitated from the culture with 50% (wt/vol) ammonium sulfate, and the affinity-purified material that was eluted from a goat antihuman IgM-Sepharose column was used.
Monoclonal with (T,G)-A--L did not bind to these antigens ( Table 2 ). It should be noted that the mice immunized with either human IgM (Table 1) or the synthetic polypeptide (Table 2) produced high antibody titers against the immunizing antigens.
Mice immunized with idiotype 16/6 antibodies had moderate leukopenia with mean leukocyte counts of 3580 + 299 cells per mm3, as compared with 4987 ± 680 cells per mm3 found in the mice immunized with the control antigens (P < 0.01). No anemia was observed. The erythrocyte sedimentation rate was significantly elevated in the idiotype 16/6-immunized mice, up to 20 times the values determined in the control group (2-15 mm per 6 hr vs. 0.5-0.75 mm per 6 hr). Some systemic manifestations, such as apathy and massive accumulation of truncal fat, were apparent. A notable amount of brown fat was also observed in the suprascapular gland.
Starting 3 months after boosting, all mice injected with the idiotype 16/6 exhibited proteinuria of 1-3 g/liter. This is in comparison with trace amounts of protein (<0.3 g/liter) detected in the mice injected with the control antigen (T,G)-A--L. The histological examination of kidney sections of the mice sacrificed 4 months after the booster injection disclosed some mild pathological changes in the glomeruli, as shown in Fig. LA. Fig. 1B shows kidney sections of mice sacrificed 12 months after the booster injection. The latter exhibited a focal sclerosis of the glomeruli. Immunohistochemical staining 4 months after the booster injection revealed immune complexes of both IgM and IgG isotypes in the glomerular basal membrane (data not shown). The existence of these complexes was confirmed by electron microscopy (Fig. 2) as electron-dense deposits were found in the paramesangial tissue. Fig. 3 shows staining of the kidney sections with a specific monoclonal antibody (1A3-2) prepared against the 
DISCUSSION
In the present study we have induced an SLE-like disease in a mouse strain that is not susceptible to spontaneous autoimmune diseases. The injection of the common human anti-DNA idiotype (idiotype 16/6) was followed by the appearance of several hallmarks of SLE disease in human and in the spontaneous murine models (NZB/W F1, MRL/lpr/ lpr, and BXSB) for this disease. The manifestations included elevated titers of antinuclear antibodies, such as anti-ssDNA, anti-dsDNA, anti-SS-A, anti-SS-B, anti-ribonucleoprotein, and anti-Sm antibodies, as well as antibodies to the synthetic polynucleotides poly(I) and poly(dT). Anti-Sm antibodies were reported to be highly specific for SLE (15) and rarely appear in other autoimmune diseases. The idiotype 16/6 that was found in the immunized mice was also reported to appear in 56% of active SLE patients and to parallel disease activity (8) . Since it has been shown (7) (5) . Some of these had high affinity to DNA, were of the IgG isotype, and had alkaline isoelectric points, thus suggesting that they were a nephrogenic subpopulation of the anti-DNA antibodies (17) . Yet, none of these antibodies induced SLElike disease in mice. Furthermore, injection of NZB/W F1 mice with a syngeneic monoclonal anti-DNA antibody with an alkaline isoelectric point was followed by a transient clinical improvement (18) . Some of the differences between the system in the present report and that used in previous studies may explain the efficient induction of the SLE-like disease. The antibody with the idiotype 16/6, in contrast to other monoclonal anti-DNA antibodies used, is a human IgM and thus is more potent to the murine immune system. In addition, it was administered intradermally with CFA in contrast to other studies, in which the anti-DNA antibodies were injected either i.v. (6) This model of expenmental SLE-like disease in mice demonstrates the involvement of the idiotype-anti-idiotype network in SLE and may be further employed for the better understanding of the mechanisms involved in the induction and development of this disease.
